Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Xylem Inc (NYSE: XYL) closed at $139.7 in the last session, down -0.46% from day before closing price of $140.35. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 1.11 million shares were traded. XYL stock price reached its highest trading level at $140.725 during the session, while it also had its lowest trading level at $139.04.
Ratios:
We take a closer look at XYL’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.60. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on May 30, 2025, initiated with a Overweight rating and assigned the stock a target price of $148.
Citigroup Upgraded its Neutral to Buy on December 09, 2024, whereas the target price for the stock was revised from $135 to $148.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 18 ’25 when Glatch Lisa sold 4,900 shares for $140.66 per share. The transaction valued at 689,231 led to the insider holds 5,163 shares of the business.
Lisa Glatch bought 4,900 shares of XYL for $690,165 on Aug 18 ’25. On Aug 04 ’25, another insider, Harker Victoria D, who serves as the Director of the company, sold 1,800 shares for $143.63 each. As a result, the insider received 258,542 and left with 18,575 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XYL now has a Market Capitalization of 34004375552 and an Enterprise Value of 35193331712. As of this moment, Xylem’s Price-to-Earnings (P/E) ratio for their current fiscal year is 36.31, and their Forward P/E ratio for the next fiscal year is 25.91. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.90 while its Price-to-Book (P/B) ratio in mrq is 3.07. Its current Enterprise Value per Revenue stands at 4.031 whereas that against EBITDA is 19.749.
Stock Price History:
The Beta on a monthly basis for XYL is 1.13, which has changed by 0.09115052 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, XYL has reached a high of $145.33, while it has fallen to a 52-week low of $100.47. The 50-Day Moving Average of the stock is 2.36%, while the 200-Day Moving Average is calculated to be 10.99%.
Shares Statistics:
According to the various share statistics, XYL traded on average about 1.17M shares per day over the past 3-months and 1098110 shares per day over the past 10 days. A total of 243.40M shares are outstanding, with a floating share count of 242.76M. Insiders hold about 0.27% of the company’s shares, while institutions hold 93.17% stake in the company. Shares short for XYL as of 1755216000 were 2434766 with a Short Ratio of 2.09, compared to 1752537600 on 2180543. Therefore, it implies a Short% of Shares Outstanding of 2434766 and a Short% of Float of 1.28.
Dividends & Splits
The forward annual dividend rate for XYL is 1.56, which was 1.52 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.010830067The stock’s 5-year Average Dividend Yield is 1.13.
Earnings Estimates
The company has 18.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $1.31, with high estimates of $1.38 and low estimates of $1.28.
Analysts are recommending an EPS of between $4.9 and $4.7 for the fiscal current year, implying an average EPS of $4.82. EPS for the following year is $5.39, with 20.0 analysts recommending between $5.61 and $5.15.
Revenue Estimates
According to 19 analysts, the current quarter’s revenue is expected to be $2.22B. It ranges from a high estimate of $2.26B to a low estimate of $2.2B. As of the current estimate, Xylem Inc’s year-ago sales were $2.1BFor the next quarter, 19 analysts are estimating revenue of $2.36B. There is a high estimate of $2.39B for the next quarter, whereas the lowest estimate is $2.32B.
A total of 19 analysts have provided revenue estimates for XYL’s current fiscal year. The highest revenue estimate was $9.01B, while the lowest revenue estimate was $8.91B, resulting in an average revenue estimate of $8.95B. In the same quarter a year ago, actual revenue was $8.56BBased on 20 analysts’ estimates, the company’s revenue will be $9.41B in the next fiscal year. The high estimate is $9.52B and the low estimate is $9.23B.
